FDA Update: GSMS Recalls Atenolol and Clopidogrel Tablets Due to Label Mix-up

The U.S. Food and Drug Administration (FDA) on Sept. 29 released a MedWatch announcement noting that Golden State Medical Supply (GSMS) is recalling Clopidogrel 75mg Tablets that were mislabeled as Atenolol 25mg Tablets.

Clopidogrel is commonly prescribed to lower the risk of stroke, blood clot or other severe heart problem, while Atenolol is used to treat hypertension. The recall is only for products with lot# GS046745, and both products are being recalled out of an abundance of caution.

Access the FDA website for more information about this recall.

Clinical Topics: Prevention, Hypertension

Keywords: ACC Advocacy, United States Food and Drug Administration, Clopidogrel, Atenolol, Hypertension, Thrombosis, Tablets, Stroke

< Back to Listings